arrow
S

Shephal K. Doshi

Pacific Heart Institute
H指数:30
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of linear ablation in persistent atrial fibrillation using a dual energy, wide-footprint catheter - Analysis from the SPHERE Per-AF Randomized Trial
2026-02-060
PRE
Same day discharge can be performed safely after atrial fibrillation catheter ablation using a wide-footprint lattice-tip dual-energy system
2026-01-210
OAAI
Operator learning curve with a novel dual-energy lattice-tip ablation system

操作者学习曲线:一种新型双能量晶格电极消融系统

2026-01-012
PRE
Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US

40,000例以上患者中脉冲场消融安全性的多中心研究:MANIFEST-US

JACC
IF0
2025-11-100
PRE
Ultrasound-Based Renal Sympathetic Denervation as Adjunctive Upstream Therapy During Atrial Fibrillation Ablation

基于超声的肾交感去神经支配作为心房颤动消融期间附加的上游疗法

2025-10-310
PRE
Evaluation of a second-generation intercostal extravascular implantable cardioverter defibrillator lead with a pectoral pulse generator for sensing, defibrillation, and anti-tachycardia pacing

评估一种第二代肋间血管外植入式心律转复除颤器电极,该电极与胸壁脉冲发生器配合用于感知、除颤和抗心动过速起搏。

2025-03-030
PRE
Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Hemodialysis An International, Multicentric Registry
2025-01-010
PRE
Ischemic stroke severity and mortality after left atrial appendage closure vs nonwarfarin oral anticoagulants in patients with prior stroke
2024-11-011
PRE
Severity of Ischemic Stroke After Left Atrial Appendage Closure vs Nonwarfarin Oral Anticoagulants

左心耳封堵术与非华法林口服抗凝剂治疗后缺血性卒中的严重程度

2024-02-017
PRE
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation

在房颤患者中比较Watchman FLX装置与DOACs的随机研究的原理和设计

2023-10-0114
OAAI
Two-Year Outcomes With a Next-Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial

使用下一代左心耳装置的两年结果: PINNACLE FLX试验的最终结果

2023-02-2120
OAAI
Radiofrequency Energy Applications Targeting Significant Residual Leaks After Watchman Implantation A Prospective, Multicenter Experience
2021-12-0114
PRE